| c-Met+ Cytotoxic T Lymphocytes Exhibit Enhanced Cytotoxicity in Mice and Humans In Vitro Tumor Models | Biomedicines |  | | 2023 | 62 | 244 |
|
| CD4+c-Met+Itgα4+ T cell subset promotes murine neuroinflammation | Journal of neuroinflammation | | | 2022 | 240 | 137 |
|
| c-Met enforces proinflammatory and migratory features of human activated CD4+ T cells | Cellular & Molecular Immunology | | | 2021 | 341 | 259 |
|
| c-Met is expressed by highly autoreactive encephalitogenic CD8+ cells | Journal of neuroinflammation | | | 2020 | 3 | 2 |
|
| In-vivo gp100-specific Cytotoxic CD8+ T Cell Killing Assay | Bio-protocol | | | 2018 | 332 | 626 |
|
| Activation of human B cells negatively regulates TGF-β1 production | Journal of Neuroinflammation | | | 2017 | 599 | 325 |
|
| Transmembrane Tumor Necrosis Factor Controls Myeloid-Derived Suppressor Cell Activity via TNF Receptor 2 and Protects from Excessive Inflammation during BCG-Induced Pleurisy | Frontiers in Immunology | | | 2017 | 456 | 287 |
|
| Identification of a novel population of highly cytotoxic c-Met-expressing CD8(+) T lymphocytes | EMBO Reports |  | | 2017 | 602 | 4 |
|
| B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation | Scientific reports | | | 2016 | 631 | 325 |
|
| Hepatocyte growth factor: A regulator of inflammation and autoimmunity | Autoimmunity reviews | | | 2015 | 568 | 0 |
|
| The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cells | Journal of neuroimmunology | | | 2014 | 555 | 0 |
|
| TLR7 signaling exacerbates CNS autoimmunity through downregulation of Foxp3(+) Treg cells | European Journal of Immunology | | | 2014 | 674 | 1 |
|
| Hepatocyte growth factor limits autoimmune neuroinflammation via glucocorticoid-induced leucine zipper expression in dendritic cells | The Journal of immunology | | | 2014 | 700 | 3 |
|
| The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity | Journal of neuroinflammation | | | 2013 | 634 | 406 |
|
| Nogo-A downregulation improves insulin secretion in mice | Diabetes | | | 2013 | 711 | 353 |
|
| Selective APRIL blockade delays systemic lupus erythematosus in mouse | PloS one | | | 2012 | 621 | 317 |
|
| IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis | Journal of neuroinflammation | | | 2012 | 730 | 363 |
|
| Interferon-β induces hepatocyte growth factor in monocytes of multiple sclerosis patients | PloS one | | | 2012 | 696 | 280 |
|
| Antibody response in MOG35–55 induced EAE | Journal of neuroimmunology | | | 2011 | 771 | 917 |
|
| Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action | CNS drugs | | | 2011 | 610 | 0 |
|
| Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease | PloS one | | | 2010 | 770 | 861 |
|
| Immunomodulatory effects of hepatocyte growth factor in experimental autoimmune encephalomyelitis | | | | 2010 | 1,105 | 1,538 |
|
| MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity | The Journal of experimental medicine | | | 2010 | 705 | 1 |
|
| Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells | Proceedings of the National Academy of Sciences of the United States of America | | | 2010 | 728 | 0 |
|
| Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis | Proceedings of the National Academy of Sciences of the United States of America | | | 2009 | 649 | 0 |
|
| Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients | Journal of neuroimmunology | | | 2008 | 679 | 0 |
|
| Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model | International immunology | | | 2008 | 650 | 1 |
|
